CBDX (Curative Biosciences) EBIT per Share: $-0.03 (TTM As of Mar. 2018)


What is Curative Biosciences EBIT per Share?

Curative Biosciences CBDX EBIT per Share is $-0.03 as of Mar. 2018.

Curative Biosciences's EBIT per Share for the three months ended in Mar. 2018 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2018 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Curative Biosciences's EBIT per Share or its related term are showing as below:

CBDX's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.55
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Curative Biosciences's EBIT for the three months ended in Mar. 2018 was $-0.03 Mil.

Curative Biosciences  (OTCPK:CBDX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Curative Biosciences EBIT per Share Related Terms

Curative Biosciences EBIT per Share Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences EBIT per Share Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.52 -0.13 -0.22 -0.12 -0.00

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.03 -0.00

Curative Biosciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Curative Biosciences's EBIT per Share for the fiscal year that ended in Jun. 2017 is calculated as

EBIT per Share(A: Jun. 2017 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.053/15.708
=-0.00

Curative Biosciences's EBIT per Share for the quarter that ended in Mar. 2018 is calculated as

EBIT per Share(Q: Mar. 2018 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.032/19.575
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.03 mean?
Curative Biosciences (CBDX) has a EBIT per Share of $-0.03 as of Mar. 2018. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Curative Biosciences and its competitors.
Is Curative Biosciences' EBIT per Share too high?
Curative Biosciences' current EBIT per Share is $-0.03.
How does Curative Biosciences' EBIT per Share compare to ACUR and CVLB?
Curative Biosciences' EBIT per Share of $-0.03 can be compared against companies in the Drug Manufacturers industry. The industry median EBIT per Share is 7.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.55, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Curative Biosciences and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curative Biosciences's current EBIT per Share is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biosciences stock overvalued right now?
Curative Biosciences (CBDX) has a current EBIT per Share of $-0.03. The current EBIT per Share is $-0.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Curative Biosciences (CBDX), the current EBIT per Share is $-0.03 as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.